Source: Annual Congress 2004 - Practical issues in the management of childhood asthma
Disease area: Airway diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. F. Zhoukova, E. G. Kondiourina, T. N. Elkina, R. M. Zakrevskaya (Novosibirsk, Russia). Factors resulting in uncontrolled severe persistent asthma in children. Eur Respir J 2004; 24: Suppl. 48, 243

Member's Comments

No comment yet.

Related content which might interest you: Risk factors for severe exacerbations in a real-life population of adults with severe refractory asthma Source: International Congress 2017 – Many faces of asthma and allergies Year: 2017 Factors associated with frequent exacerbations in patients with severe asthma Source: Eur Respir J 2001; 18: Suppl. 33, 369s Year: 2001 Distribution of biomarkers in severe asthma and severe uncontrolled asthma Source: Virtual Congress 2021 – Pearls in asthma and respiratory burden research Year: 2021 Predictors of severe exacerbations in patients with moderate and severe asthma Source: International Congress 2018 – Determinants and monitoring of asthma control Year: 2018 Efficacy of tezepelumab in adolescents with severe, uncontrolled asthma Source: Virtual Congress 2021 – Asthma treatment: clinical and translational science Year: 2021 Dupilumab improves lung function and reduces severe exacerbations in uncontrolled persistent asthma patients with ongoing allergic rhinitis Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside Year: 2017 Long-term results of anti-IgE-therapy in severe uncontrolled child asthma. Source: International Congress 2018 – New developments in the treatment of asthma Year: 2018 Management of severe asthma in children Source: International Congress 2018 – ME11 Management of severe asthma in children FULLY BOOKED Year: 2018 Management of severe asthma in children Source: Virtual Congress 2020 – Reducing the burden of asthma Year: 2020 Management of severe asthma in children Source: Annual Congress 2010 - ERS/[italic]Lancet[/italic] Asthma Year: 2010 ME11 Management of severe asthma in children Source: Paris 2018 - Educational material Year: 2018 Risk factors for severe asthma attacks in Romanian children Source: Eur Respir J 2006; 28: Suppl. 50, 253s Year: 2006 Dupilumab efficacy in children with uncontrolled, moderate-to-severe asthma with and without an allergic phenotype Source: Virtual Congress 2021 – Advances in childhood asthma: biologics, biomarkers and infections Year: 2021 Risk factors for severe asthma among adults with asthma Source: Virtual Congress 2020 – Diagnosis and management of asthma Year: 2020 Severe asthma in children Source: CME Online 2011 Year: 2011 Severe asthma in children Source: International Congress 2015 – Fingerprinting severe asthma Year: 2015 Management of difficult-to-treat severe asthma Source: Eur Respir Mon 2011; 51: 282-296 Year: 2011 Which are the factors and causes that lead to omalizumab withdrawal in severe asthma patients? Source: International Congress 2018 – New developments in the treatment of asthma Year: 2018 Dupilumab improves asthma control and quality of life in children with uncontrolled persistent asthma Source: Virtual Congress 2021 – Paediatric allergic asthma: novel therapeutics and monitoring approaches Year: 2021 The impact of targeted therapy in children with uncontrolled allergic persistent severe asthma and nasal polyps Source: International Congress 2017 – Paediatric asthma: therapies and comorbidities Year: 2017